Compare NRXS & BTTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRXS | BTTC |
|---|---|---|
| Founded | 2011 | 1990 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.7M | 40.5M |
| IPO Year | 2023 | N/A |
| Metric | NRXS | BTTC |
|---|---|---|
| Price | $4.46 | $1.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | 899.5K | ★ 2.8M |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | ★ $3,362,320.00 | $2,719,480.00 |
| Revenue This Year | $31.05 | N/A |
| Revenue Next Year | $137.61 | N/A |
| P/E Ratio | ★ N/A | $2.32 |
| Revenue Growth | ★ 36.89 | 2.04 |
| 52 Week Low | $1.33 | $1.62 |
| 52 Week High | $6.20 | $39.00 |
| Indicator | NRXS | BTTC |
|---|---|---|
| Relative Strength Index (RSI) | 76.30 | N/A |
| Support Level | $2.63 | N/A |
| Resistance Level | $4.70 | N/A |
| Average True Range (ATR) | 0.40 | 0.00 |
| MACD | 0.17 | 0.00 |
| Stochastic Oscillator | 92.75 | 0.00 |
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Black Titan Corp is engaged in software implementation and training. It provides consulting services and Human Resource and Payroll solutions.